Skip to content
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
  • Make an Appointment
  • Find a Doctor
  • Contact Us
  • About Dana-Farber
  • About Insight

Search Results for: multiple myeloma

Standing up Against Multiple Myeloma Starts with a PROMISE

by Dana-Farber Staff

…the Stand Up to Cancer (SU2C) multiple myeloma “dream team” — a multidisciplinary, inter-institutional group focused on addressing critical problems in multiple myeloma prevention, diagnosis, and treatment. It aims to…

Categories Blood Cancer, Multiple Myeloma, Patient Stories, Adult 6 Comments

Multiple Myeloma Presents Added Burden for African Americans

by Dana-Farber Staff

…coverage, may play a role. What is multiple myeloma? Multiple myeloma is a cancer of the bone marrow involving plasma cells, which are mature white blood cells that produce antibodies….

Categories Blood Cancer, Inclusion, Diversity & Equity, Multiple Myeloma

Study Exploring Relationship Between Precursor Conditions and Multiple Myeloma

by Dana-Farber Staff

…multiple myeloma. The researchers study two precursor conditions of multiple myeloma: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). MGUS is a pre-malignant condition in which an…

Categories Multiple Myeloma

Signs and Symptoms of Multiple Myeloma

by Dana-Farber Staff

…As the population of myeloma cells in the bone marrow expands, fewer red blood cells, white blood cells, and platelets are produced. Symptoms of multiple myeloma Sometimes, multiple myeloma does…

Categories General interest, Multiple Myeloma

Research Advances Hold Promise for Multiple Myeloma Treatment

by Dana-Farber Staff

…well as blocking the pathways that trigger these interactions, which include both novel agents (so-called small molecules) and monoclonal antibodies. Read more: What is Multiple Myeloma? A History of Multiple…

Categories Cancer research, Multiple Myeloma 1 Comment

CAR T-Cell Therapy Pushes Grandmother’s Multiple Myeloma Into Long Remission

by Dana-Farber Staff

As head of a family that includes seven children and 12 grandchildren, Susan Voigt says she is used to putting other people first. When it comes to trailblazing multiple myeloma…

Categories Blood Cancer, CAR T-cell therapy, General Adult and Pedi, Multiple Myeloma, Patient Stories, Adult, Research 6 Comments

Immunotherapies Producing Dramatic Results in Multiple Myeloma

by Dana-Farber Staff

…Correlative Science at Dana-Farber’s Jerome Lipper Center for Multiple Myeloma. A cell being attacked and killed by CAR cells. CAR T-cell therapy is a form of immunotherapy. Immunotherapies for myeloma…

Categories Multiple Myeloma 1 Comment

New Therapies Bring Progress Against Multiple Myeloma

by Dana-Farber Staff

…with multiple myeloma for 20 years. Bond credits Dana-Farber’s clinical trials for his longevity. Multiple myeloma leaders Paul Richardson, Nikhil Munshi, and Ken Anderson (left to right) Multiple myeloma is…

Categories Care for adults, Multiple Myeloma, Treatments and Procedures 23 Comments

What is Minimal Residual Disease Negativity for Multiple Myeloma?

by Dana-Farber Staff

…the Jerome Lipper Multiple Myeloma Center at Dana-Farber. An illustration of multiple myeloma cells. Since 2006, when physicians adopted uniform international standards for monitoring patients with multiple myeloma and gauging…

Categories Multiple Myeloma

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

by Dana-Farber Staff

For many patients with multiple myeloma, a new generation of drugs and drug combinations is producing better outcomes and fewer side effects. In recent months, several novel therapies studied and…

Categories Blood Cancer, Dana-Farber Research, Multiple Myeloma, Research 5 Comments

Multiple Myeloma: Optimizing Quality of Life for Survivors

by Dana-Farber Staff

Multiple myeloma cells. Thanks to major advances in treatment in recent years, patients diagnosed with multiple myeloma today have a much greater life expectancy, even though the blood cancer isn’t…

Categories Multiple Myeloma

What is the Role of Genetic Analysis in Multiple Myeloma?

by Dana-Farber Staff

…myeloma cells, predict poorer outcome and shorter survival, says Nikhil Munshi, MD, director of basic and correlative sciences at Dana-Farber’s Jerome Lipper Multiple Myeloma Center. Some of those higher-risk genetic…

Categories Multiple Myeloma

Brokaw Diagnosis: What is Multiple Myeloma?

by Dana-Farber Staff

…in multiple myeloma patients overall,” says Richardson, clinical director for the Dana-Farber/Brigham and Women’s Cancer Center Jerome Lipper Center for Multiple Myeloma, and the R.J. Corman Professor of Medicine, Harvard…

Categories Cancer research, Care for adults, Multiple Myeloma 3 Comments

A History of Multiple Myeloma Advances

by Dana-Farber

…improved treatment for multiple myeloma over the past three decades. For the past two decades, much of that work has taken place at the Jerome Lipper Multiple Myeloma Center and…

Categories Cancer research, Multiple Myeloma 8 Comments

Study Uncovers Dual Gene-Control System in Multiple Myeloma

by Dana-Farber Staff

…for controlling promoters and enhancers in multiple myeloma. The finding may, on the one hand, help explain why myeloma often rebounds after drug treatment (therapies that stymie just one control…

Categories Dana-Farber Research, Multiple Myeloma, Research 2 Comments

Multiple Myeloma Fails to Keep Jimmy Cefalo Out of Action

by Dana-Farber Staff

…to clinical trial Cefalo was initially diagnosed with smoldering multiple myeloma, an early form of the condition that typically leads to active myeloma — especially in patients potentially at high risk…

Categories Adult, Blood Cancer, Multiple Myeloma, Patient Stories, Adult 11 Comments

Bispecific Antibodies for Multiple Myeloma: Six Things to Know 

by Rob Levy

In 2022, the drug teclistamab became the first bispecific antibody to be approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. Experts say the…

Categories Adult, Blood Cancer, Multiple Myeloma, Research 2 Comments

CAR T-Cell Clinical Trial Has Multiple Myeloma Patient Back On Her Feet

by Dana-Farber Staff

…the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute, which had long partnered in her care. Trial participants were receiving CAR T-cell therapy,…

Categories CAR T-cell therapy, Multiple Myeloma, Patient Stories, Adult

Patient and Author with Multiple Myeloma is Writing His Own Next Chapter

by Dana-Farber Staff

…the same time; relieved that the treatment would arrest progression of myeloma,” recalls Palayoor. Working towards a single goal While multiple myeloma is not curable, it can be managed with…

Categories Blood Cancer, Multiple Myeloma, Patient Stories, Adult 1 Comment

Remembering My Father’s Journey with Multiple Myeloma

by Dana-Farber Staff

…College, Marathons and Multiple Myeloma What is Multiple Myeloma? Even though my dad is no longer with us, this story doesn’t have an end. Sometimes the conversations are hard, but…

Categories Care for adults, General interest, Multiple Myeloma 34 Comments
Older posts
Page1 Page2 … Page18 Next →

Make an Appointment or Get a Second Opinion

Boston (Main Campus)

Adults: 877-442-3324
Pediatric: 888-733-4662

Make an Appointment

Our Online Second Opinion program lets adult patients from all over the world receive expert second opinions from Dana-Farber oncologists without leaving home.

Get a Second Opinion Online

Get A Weekly Insight Email

Get our weekly newsletter that'll tell you exactly what you need to know in the cancer world.

About Our Patient Stories

Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

Why You Can Trust Insight

Insight is committed to bringing you information about cancer that you can trust and that meets the highest editorial and scientific standards. We employ a strict editorial process to ensure that what you read is factually correct. Learn more about our process here.
© 2023 Dana-Farber Cancer Institute
450 Brookline Avenue, Boston, MA 02215
Call us: 617-632-3000

About Insight | Privacy Policy | Legal Statements | Sitemap